false
0002019505
0002019505
2025-07-21
2025-07-21
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
July
21, 2025
Date
of Report (Date of earliest event reported)
Health In Tech, Inc.
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-42449 |
|
87-3545722 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
701 S. Colorado Ave, Suite 1
Stuart,
FL |
|
34994 |
| (Address of principal executive
offices) |
|
(Zip Code) |
Registrant’s
telephone number, including area code: (888) 373-0333
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class A Common Stock, $0.001 par value per share |
|
HIT |
|
The
Nasdaq Stock Market LLC
(Nasdaq
Capital Market) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.02. Results of Operations and Financial Condition.
On
July 21, 2025, Health In Tech, Inc., a Nevada corporation (the “Company”) issued a press release announcing its results of
operations for the quarter ended June 30, 2025, attached hereto as Exhibit 99.1.
Item
7.01. Regulation FD Disclosure.
As
disclosed in Item 2.02 above, on July 21, 2025, the Company issued a press release announcing its results of operations for the quarter
ended June 30, 2025, attached hereto as Exhibit 99.1. The information set forth in Item 7.01 of this Current Report on Form 8-K and in
the attached Exhibit 99.1 are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not
be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any
general incorporation language in such filing.
Forward-Looking
Statements
Certain
statements in this Current Report on Form 8-K are forward-looking statements for purposes of the safe harbor provisions under the U.S.
Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s
possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position,
industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as
“may,” “will,” “should,” “design,” “target,” “aim,” “hope,”
“expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”
“believe,” “continue,” “predict,” “project,” “potential,” “goal,”
or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s
future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s
actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements
because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s
control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and
uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from
those presented in its forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual
Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission,
as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports.
Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and
other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and
liquidity.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits:
| Exhibit
No. |
|
Description |
| 99.1 |
|
Press release dated July 21, 2025. |
| 104 |
|
Cover Page Interactive Data File (embedded within the
Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
July 21, 2025
HEALTH
IN TECH, INC.
| By: |
/s/
Tim Johnson |
|
| Name: |
Tim Johnson |
|
| Title: |
Chief Executive Officer |
|
2
